IGWM
XFOR icon

ICA Group Wealth Management’s X4 Pharmaceuticals XFOR Stock Holding History

ICA Group Wealth Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$3.71K Buy
213
+121
+132% +$3.96K ﹤0.01% 616
2024
Q1 		$3.82K Buy
92
+6
+7% +$167 ﹤0.01% 1086
2023
Q4 		$2.16K Buy
+86
New +$2.09K ﹤0.01% 1172
2023
Q3 		– Sell
-45
Closed -$2.62K – 1254
2023
Q2 		$2.62K Buy
+45
New +$2.31K ﹤0.01% 1096

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ICA Group Wealth Management's XFOR Position: Q2 2024 in Review

ICA Group Wealth Management increased its X4 Pharmaceuticals (XFOR) stake by 132% in Q2 2024, buying an estimated $3.96K and bringing the position to 213 shares worth $3.71K. The position accounts for ﹤0.01% of the portfolio, ranked #616.

ICA Group Wealth Management first reported a position in XFOR in Q2 2023 and has held it in 4 quarters since. The position peaked at $3.82K in Q1 2024. 98 funds tracked by Wall St. Rank hold XFOR as of Q2 2024.

  • ICA Group Wealth Management held 213 shares of X4 Pharmaceuticals worth $3.71K as of Q2 2024.
  • ICA Group Wealth Management bought 121 X4 Pharmaceuticals shares in Q2 2024, an estimated $3.96K.
  • X4 Pharmaceuticals made up ﹤0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #616 holding.
  • ICA Group Wealth Management first reported a position in X4 Pharmaceuticals in Q2 2023 and has held it in 4 quarters since.
  • ICA Group Wealth Management's X4 Pharmaceuticals position peaked at $3.82K in Q1 2024.
  • 98 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.